CG Oncology Closes $47M Series D Funding - vcnewsdaily.com
CG Oncology, a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, announced the closing of a $47 million Series D preferred stock …
OFF
CG Oncology Closes $47M Series D Funding - Vcnewsdaily.com
2 days from now
CG Oncology, a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, announced the closing of a $47 million Series D preferred stock …
vcnewsdaily.com
OFF
CG Oncology Closes $47 Million Series D Financing | CG Oncology
2 days from now
Dec 10, 2020 · or. MEDIA. Kimberly Ha. KKH Advisors. (917) 291-5744. [email protected]. IRVINE, Calif., December 10, 2020 – CG Oncology, Inc., a …
cgoncology.com
OFF
CG Oncology Closes $47 Million Series D Financing - BioSpace
2 days from now
Dec 10, 2020 · IRVINE, Calif.--(BUSINESS WIRE)-- CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, …
biospace.com
OFF
CG Oncology Closes $47 Million Series D Financing
2 days from now
Dec 10, 2020 · CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced the closing of a $47 …
marketscreener.com
OFF
CG Oncology Closes $47 Million Series D Financing
2 days from now
IRVINE, Calif., December 10, 2020 – CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced …
cgoncology.com
OFF
Series D - CG Oncology - 2020-12-10 - Crunchbase Funding …
2 days from now
Dec 10, 2020 · Funding Type Series D; Funding Stage Late Stage Venture; Money Raised . $47M. Lead Investors. ... Business Wire — CG Oncology Closes $47 Million Series D …
crunchbase.com
OFF
CG Oncology Closes $47 Million Series D Financing - BioSpace
2 days from now
Dec 10, 2020 · CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, today announced the closing of a $47 …
biospace.com
OFF
Cancer Drug Developer CG Oncology Valued At $1.75 Bln In Strong …
2 days from now
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …
reuters.com
OFF
CG Oncology Announces $105 Million Oversubscribed Crossover …
2 days from now
Aug 2, 2023 · – Co-led by new investors Foresite Capital and TCGX – – Proceeds to advance late-stage clinical programs in bladder cancer towards FDA approval – August 2, 2023, 8:00 …
cgoncology.com
OFF
CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …
2 days from now
Nov 18, 2024 · CG Oncology valued at $1.75 bln in strong market debut. CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the …
stockanalysis.com
OFF
CG Oncology Closes $47 Million Series D Financing
2 days from now
On December 10, 2020 CG Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, reported the closing of a $47 million …
1stoncology.com
OFF
CG Oncology Lines Up $180m IPO And A $1bn Valuation
2 days from now
Jan 19, 2024 · CG Oncology lines up $180m IPO and a $1bn valuation. CG Oncology is the latest biotech to take a look at a share listing in the US, aiming to raise around $180 million in the …
pharmaphorum.com
OFF
CG Oncology Completes $120M Series E - Vcnewsdaily.com
2 days from now
Nov 15, 2022 · CG Oncology, an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, today announced the close of an …
vcnewsdaily.com
OFF
$22 Million Series C Financing - CG Oncology
2 days from now
– Investment to Advance Clinical Development of Oncolytic Immunotherapies in Bladder Cancer and other Solid Tumors – SANTA ANA, Calif., March 18, 2019 – Cold Genesys, Inc., a clinical …
cgoncology.com
OFF
Venture Capital News: CG Oncology Closes $47M Series D Funding
2 days from now
IRVINE, CA, CG Oncology announced the closing of a $47 million Series D preferred stock financing led by new investor Kissei Pharmaceutical Co. VC DATABASE; MOBILE APP; ...
vcnewsdaily.com
FAQs about CG Oncology Closes $47M Series D Funding - vcnewsdaily.com Coupon?
How did CG oncology raise $380 million?
Who is CG oncology?
Will CG Oncology GO Public?
How much is CG oncology worth?
Does CG oncology have a biotech IPO?
What does CG oncology stand for?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
